Global Dermal Facial Fillers Market to Be Worth $4.2 Billion by 2024 - ResearchAndMarkets.com

The "Dermal Facial Fillers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global dermal facial fillers market reached a value of US$ 2.3 Billion in 2018. Looking forward, we expect this market to reach a value of US$ 4.2 Billion by 2024, exhibiting a CAGR of 10.4% during 2019-2024.

This report provides a deep insight into the global dermal facial fillers market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc.

Market Drivers

The dermal facial fillers market is strongly being driven by an increase in the number of people seeking treatment for facial wrinkles and scarring. This increase has occurred on account of a continuous rise in an imbalance diet, stress and insomnia.

Another major driver of this market is the fact that this treatment is non-invasive and has does not take a long period of time to be conducted.

Moreover, there has been a decrease in the number of complexities which occur post-surgery. In addition to this, the surgery does not have a prominent scarring as it requires very small incisions which has positively influenced the overall growth of the market.

Other factors that are catalysing the growth of this market include a rising ageing population, increasing disposable incomes and raising awareness through social media platforms such as YouTube and Instagram.

Market Summary

Based on the material type, the market has been segmented into temporary fillers, semi-permanent fillers and permanent fillers. Currently, temporary fillers dominate the market, holding the largest share.

Based on the product origin, the market has been segmented into natural and synthetic.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

The competitive landscape of the market has also been examined with some of the key players being Allergan, Galderma, Merz Pharma, AQTIS Medical, Bioha Laboratories, Cynosure, Cosmoderm, ColBar LifeScience, Techderm, Regenerative Medical System, Suneva Medical, Sanofi, SciVision Biotech, Speciality European Pharma, Syneron, Ulthera and Visionmed.

Key Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Dermal Facial Fillers Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Material Type

5.4 Market Breakup by Product Origin

5.5 Market Breakup by Region

5.6 Market Forecast

5.7 SWOT Analysis

5.7.1 Overview

5.7.2 Strengths

5.7.3 Weaknesses

5.7.4 Opportunities

5.7.5 Threats

5.8 Value Chain Analysis

5.9 Porters Five Forces Analysis

5.9.1 Overview

5.9.2 Bargaining Power of Buyers

5.9.3 Bargaining Power of Suppliers

5.9.4 Degree of Competition

5.9.5 Threat of New Entrants

5.9.6 Threat of Substitutes

6 Market Breakup by Material Type

6.1 Temporary Fillers

6.2 Semi-Permanent Fillers

6.3 Permanent Fillers

7 Market Breakup by Product Origin

7.1 Natural

7.2 Synthetic

8 Market Breakup by Region

8.1 North America

8.2 Europe

8.3 Asia-Pacific

8.4 Middle East & Africa

8.5 Latin America

9 Dermal Facial Fillers Manufacturing Process

9.1 Product Overview

9.2 Raw Material Requirements

9.3 Manufacturing Process

9.4 Key Success and Risk Factors

10 Competitive Landscape

10.1 Market Structure

10.2 Key Players

10.3 Profiles of Key Players

10.3.1 Allergan

10.3.2 Galderma

10.3.3 Merz Pharma

10.3.4 AQTIS Medical

10.3.5 Bioha Laboratories

10.3.6 Cynosure

10.3.7 Cosmoderm

10.3.8 ColBar LifeScience

10.3.9 Techderm

10.3.10 Regenerative Medical System

10.3.11 Suneva Medical

10.3.12 Sanofi

10.3.13 SciVision Biotech

10.3.14 Speciality European Pharma

10.3.15 Syneron

10.3.16 Ulthera

10.3.17 Visionmed

For more information about this report visit https://www.researchandmarkets.com/r/i12rb5

View source version on businesswire.com: https://www.businesswire.com/news/home/20190710005463/en/